Circulating FABP4 bridges tumor-associated stromal cells to tumor stem cells and integrates adipokines to tumor-promoting signaling and lipid metabolism, thereby representing a new molecular link underlying obesity-associated breast cancer risk and mortality. Here, FABP4 is linked to breast carcinoma.